Jeena Sikho Lifecare
add_icon

Jeena Sikho Lifecare

689.65
+16.10
(2.39%)
Market Cap
₹8,572.40 Cr
PE Ratio
247.96
Volume
2,69,353.00
Day High - Low
₹695.00 - ₹668.50
52W High-Low
₹2,450.00 - ₹400.25
ann
There are new updates from the company1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
8,572.40 Cr
EPS
24.84
PB Ratio
66.64
Book Value
10.12
EBITDA
48.20
Dividend Yield
0.16 %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
0.05
Forecast For
Actual

Company News

View All News
Caret
positive
Jeena Sikho Lifecare Limited reported strong quarterly results with revenue from operations reaching Rs. 190 crores in Q2FY26, marking a 66% year-on-year growth from Rs. 114 crores in Q2FY25 and 9% quarter-over-quarter growth from Rs. 174 crores in Q1FY26. The company's profit after tax surged 121% year-on-year to Rs. 59 crores, with a 15% quarter-over-quarter increase. EBITDA grew 129% year-on-year to Rs. 92 crores, maintaining a strong margin of 48%. The healthcare provider expanded its bed capacity by 582 beds, reaching a total of 2,802 beds with 57% occupancy rate across 58 hospitals and 59 clinics. The company operates in 23 states and 100+ cities. Jeena Sikho announced a strategic partnership with Chandan Diagnostic, providing access to 40 lakh privilege cardholders and establishing diagnostic centers across their network. The company is launching 10 new OTC products by year-end and has tied up with Salesforce for improved data management and customer engagement.
positive
Jeena Sikho Lifecare has increased its bed capacity to 2,220 with an additional 400 beds under development. The company reported significant growth in outpatient services (+67%), inpatient services (+57%), and daycare services (+169%). The company is focusing on the high-margin private sector and plans to launch 6 new Ayurvedic products. It is enhancing its digital infrastructure through a Salesforce partnership. The company maintains a 71% ROCE and has achieved a 47% three-year CAGR. It operates 46 NABH-accredited centres and aims to expand its Ayurvedic healthcare network nationwide using an asset-light strategy and AI efficiency.
positive
Jeena Sikho Lifecare delivered robust quarterly results with net profit surging to 588 million rupees from 266 million rupees year-over-year, representing a 121% increase. Revenue grew significantly to 1.9 billion rupees compared to 1.14 billion rupees in the same period last year, marking a 67% growth. EBITDA more than doubled to 921 million rupees from 403 million rupees year-over-year. The company's EBITDA margin expanded substantially to 48.49% from 35.30% in the previous year, indicating improved operational efficiency and profitability.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,807.20
#1 4,33,607.82
40.88
#1 54,729.00
9.71
#1 10,980
2.89
61.05
6,430.00
1,70,696.30
67.22
9,712.00
18.67
2,191
35.10
49.41
3,799.00
1,28,575.42
59.98
11,539.40
6.99
1,911
30.46
60.62
1,512.30
1,22,156.65
22.14
28,409.50
7.12
5,291
3.71
47.64
1,273.50
1,06,288.06
#1 18.20
33,741.20
16.73
5,725
-0.38
57.95
2,081.80
95,087.16
21.59
22,909.50
13.74
3,306
#1 72.75
59.68
922.55
92,830.12
18.48
23,511.00
18.55
4,615
34.60
37.29
2,166.80
89,436.51
49.98
12,744.20
#1 20.90
2,007
-21.05
30.56
1,172.20
68,081.57
19.89
32,345.60
9.43
3,484
3.81
45.41
5,626.00
67,267.27
27.77
13,458.30
3.70
2,216
10.98
48.53

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
40.07 %
Net Income Growth
199.11 %
Cash Flow Change
-11.19 %
ROE
-13.14 %
ROCE
-17.44 %
EBITDA Margin (Avg.)
76.14 %

Yearly Financial Results

Annual Financials
2022
2023
TTM
Revenue
148
207
0
Expenses
129
159
0
EBITDA
20
48
0
Operating Profit %
12 %
22 %
0 %
Depreciation
3
3
0
Interest
1
1
0
Profit Before Tax
15
44
0
Tax
4
11
0
Net Profit
11
34
0
EPS in ₹
11.11
24.84
0.00

Balance Sheet

Balance Sheet
2022
2023
2025
Total Assets
62
151
419
Fixed Assets
29
60
208
Current Assets
22
78
136
Capital Work in Progress
5
1
11
Investments
0
5
12
Other Assets
28
86
0
Total Liabilities
62
151
419
Current Liabilities
24
25
73
Non Current Liabilities
1
1
89
Total Equity
37
126
256
Reserve & Surplus
26
112
232
Share Capital
10
14
25

Cash Flow

Cash Flow
2022
2023
Net Cash Flow
-7
29
Investing Activities
-19
-33
Operating Activities
16
15
Financing Activities
-5
48

Share Holding

% Holding
Sept 2021
Feb 2022
Apr 2022
Sept 2022
Mar 2023
Sept 2023
Nov 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Aug 2025
Sept 2025
Promoter
90.00 %
90.00 %
65.89 %
65.89 %
66.20 %
67.91 %
67.91 %
67.91 %
65.84 %
63.53 %
63.53 %
63.53 %
63.61 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.99 %
6.59 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.18 %
0.15 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
10.00 %
10.00 %
20.05 %
16.21 %
15.28 %
14.41 %
14.94 %
17.34 %
16.72 %
16.67 %
17.05 %
17.20 %
17.32 %
Others
0.00 %
0.00 %
14.06 %
17.90 %
18.52 %
17.68 %
17.15 %
14.75 %
17.44 %
19.80 %
19.41 %
13.10 %
12.33 %
No of Share Holders
7
6
1,951
834
663
814
1,107
2,721
3,423
5,967
6,603
7,434
16,362

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.47
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.81

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Aug 2023 DIVIDEND Dividend
₹ 2.00 /share
25 Aug 2023 333.00 1,065.05
02 Nov 2023 BONUS Bonus
4:5
02 Nov 2023 1,195.50 1,403.25
27 Feb 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
27 Feb 2024 641.00 857.80
20 Aug 2024 DIVIDEND Dividend
₹ 4.18 /share
20 Aug 2024 1,121.40 1,416.40
28 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Aug 2024 1,147.00 1,351.20
11 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2024 1,723.10 1,706.30
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 2,284.55 2,353.90
21 Apr 2025 SPLIT Split
2:10
12 Jun 2025 2,251.25 2,251.25
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 547.35 560.70
22 Sept 2025 DIVIDEND Dividend
₹ 1.10 /share
22 Sept 2025 2,353.90 817.80
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 702.30 802.15
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 743.80 782.00

Announcements

Intimation Of In-Principle Approval Received For Listing Of Up To A Maximum Of 250000 Equity Shares Of Rs. 2/-Each Of Jeena Sikho Lifecare Limited To Be Issued Under Jeena Sikho Employees Stock Option Scheme 2025.1 day ago
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Publication Of Case Studies.3 days ago
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Publication Of Research Articles Case Studies And Case Report.8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 26, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Publication Of Research Articles And Case StudiesNov 25, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 12, 2025
Empanelment Of Jeena Sikho Lifecare Limited Ayurveda Panchkarma Hospital With Maruti Suzuki India Limited For Providing Cashless Ayurveda Panchkarma TreatmentNov 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Appointment Of M/S Deepak K Garg & Associates As The Internal Auditors For FY 2025-26Nov 06, 2025
Results-Financial Results For Quarter Ended 30Th September 2025Nov 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th November 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Board Meeting Intimation for Prior Intimation And Trading Window Closure Of The Board Meeting To Be Held On November 06 2025.Nov 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 14, 2025
Additional Information Regarding Corporate Announcement For Outcome Of Board Meeting Dated 13Th October 2025Oct 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th October 2025Oct 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Closure of Trading WindowSep 27, 2025
Commencement Of Operations Of New Hospital In Raigad District MaharashtraSep 24, 2025
Intimation Regarding Conferment Of Grand Records Honorary CertificateSep 22, 2025
Intimation Of Receiving The 6Th National Atal Award 2025 In The Category Of Indian Ayurveda.Sep 22, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionSep 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 12, 2025
Intimation Under Regulation 30 Of SEBI (LODR) - Collaboration With Salesforce For Digital Transformation In Ayurvedic HealthcareSep 12, 2025
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Commencement Of Operations Of New Hospital At JammuSep 12, 2025
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Approval Of Clinical Trial Of Anti-Diabetes Efficacy Of SDM02 TABLETS Shuddhi XS Syrup Petshuddhi Churna And Shuddhi Dr. B P Care Tablets.Sep 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Publication Of Case Studies And Reports.Sep 05, 2025
Proposal For Establishment Of New Branch Of Jeena Sikho Lifecare Limited Hospital In Bhagalpur BiharSep 04, 2025
Empanelment Of Jeena Sikho Lifecare Limited Ayurveda Panchkarma Hospital With GIPSA For Providing Cashless Ayurveda Panchkarma Treatment.Sep 04, 2025
Reg. 34 (1) Annual Report.Sep 03, 2025
Weblink For Notice Of 8Th Annual General Meeting And Annual Report For The Financial Year 2024-25Sep 03, 2025
Business Responsibility and Sustainability Reporting (BRSR)Sep 03, 2025
Notice Of The 8Th Annual General Meeting And Integrated Annual Report For Financial Year 2024-25Sep 03, 2025
Intimation Of Record Date For Final Dividend Under Regulation 42 Of SEBI (LODR) Regulations 2015.Aug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Publication Of Case StudiesAug 28, 2025
The Board At Its Meeting Held On 27Th August 2025 Decided To Hold The 8Th Annual General Meeting Of The Company On Monday 29Th September 2025 At 12:00 Noon.Aug 27, 2025
Book Closure Of The Register Of Members And Share Transfer Books Of The Company From Tuesday September 23 2025 To Monday September 29 2025 (Both Days Inclusive) For The 8Th Annual General Meeting.Aug 27, 2025
Approval Of Jeena Sikho Lifecare Limited Employee Stock Option Scheme 2025Aug 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 27, 2025
Fixation Of Dividend Record DateAug 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th August 2025Aug 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 23, 2025
Board Meeting Intimation for 1. To Consider And Approve The Proposal For Employee Stock Option Scheme 2025 In Terms Of SEBI (Share Based Employee Benefits And Sweat Equity) Regulations 2021. 2. To Consider Any Other Matter With The Permission Of The ChaiAug 23, 2025

Technical Indicators

RSI(14)
Neutral
39.04
ATR(14)
Less Volatile
28.62
STOCH(9,6)
Oversold
17.95
STOCH RSI(14)
Oversold
18.38
MACD(12,26)
Bearish
-3.23
ADX(14)
Weak Trend
12.03
UO(9)
Bearish
37.27
ROC(12)
Downtrend And Accelerating
-1.44
WillR(14)
Oversold
-86.77